A phase II study of weekly docetaxel and cisplatin plus oral tegafur/uracil and leucovorin as first-line chemotherapy in patients with locally advanced or metastatic gastric cancer

C. P. Li*, J. S. Chen, L. T. Chen, C. J. Yen, K. D. Lee, W. P. Su, P. C. Lin, C. H. Lu, H. J. Tsai, Y. Chao

*Corresponding author for this work

Research output: Contribution to journalJournal Article peer-review

15 Scopus citations

Fingerprint

Dive into the research topics of 'A phase II study of weekly docetaxel and cisplatin plus oral tegafur/uracil and leucovorin as first-line chemotherapy in patients with locally advanced or metastatic gastric cancer'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science